Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.
Sensex dives 850 pts, Nifty slips below 24,200 amid oil shock and weak global cues
The equity benchmark indices Sensex and Nifty tumbled on Thursday, extending losses for a second straight session. Firm crude oil prices and ongoing geopolitical tensions rattled sentiment. Brent crude surged for the fourth consecutive day to around $103 per barrel amid uncertainty over US-Iran talks and fresh concerns around the Strait of Hormuz. Weak Asian cues and persistent foreign fund outflows deepened the sell-off. The Nifty slipped below the 24,200 mark, dragged by auto, PSU banks and consumer durables stocks, while pharma and healthcare shares saw selective buying. Investors stayed cautious, closely tracking the ongoing Q4 earnings season for further triggers.
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12% - scanx.trade
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12%scanx.trade
MF Favourites take a hit: 14 smallcap stocks slide up to 50% in 3 months
Despite rising mutual fund stakes, several smallcap stocks have plunged up to 47% in 2026, highlighting market uncertainty and raising questions on whether these beaten-down picks offer value or further downside.

GSP Crop Science IPO opens today; should you apply? Here's what brokerages say
Ahead of the issue opening, agrochemical company GSP Crop Science raised ₹120 crore from two anchor investors. Mauritius-based Craft Emerging Market Fund PCC was the largest investor in the anchor book, purchasing nearly 25 lakh shares through two investment vehicles - Citadel Market Fund and Elite Capital Fund - for ₹80 crore. Shine Star Build Cap was the other anchor investor, acquiring 12.5 lakh shares worth ₹40 crore.

Kotak Mahindra Mutual Fund acquires stake in this recently listed healthcare stock
Kotak Mahindra Mutual Fund (KMMF) has raised its stake in the North Indian hospital network Park Medi World Limited to more than 5%. The fund purchased 175,164 shares, bringing its total ownership to 5.0393%, which necessitates a regulatory announcement in accordance with SAST regulations.

Top Gainers & Losers on Mar 12: Piramal Pharma, Tejas Networks, Apollo Tyres, PG Electroplast among top losers
The Indian stock market extended its losses on March 12, with the Nifty 50 and Sensex down 1% and 1.08%. Tensions in the Middle East affected investor sentiment, particularly impacting auto stocks, while broader markets showed some positive movement.
India gains favour with global investors on returns, ESG momentum
India is maturing as a market in which foreign investors who take into account environmental, social and governance (ESG) factors are confident in dedicating more of their portfolio to, according to fund managers at the Indian Venture and Alternate Capital Association conclave in Mumbai, who cite the economy's scale, improving return outlook and advancing ESG standards as key differentiators.

Stock market today: Trade setup for Gift Nifty 50, US-Iran war, crude oil, gold, silver rates — 8 stocks to buy or sell
Stock market today: Experts have recommended eight stocks to buy today — Reliance Industries, Balrampur Chini Mills, Jubilant FoodWorks, AB Capital, MCX, Ather Energy, Godrej Agrovet, and Yatharth Hospital

PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore
HDFC Mutual Fund (MF) and SBI MF have collectively acquired 93,01,020 shares or 1.65% holding in Anthem Biosciences at an average price of Rs 621.10 apiece.
Market Trading Guide: Apollo Pipes among 3 stock recommendations for Tuesday
Sensex and Nifty plunged nearly 2% as rising crude oil prices, weak global cues and escalating West Asia tensions triggered heavy selling. Foreign fund outflows and a weaker rupee added pressure. Analysts recommend Apollo Pipes, Aurobindo Pharma and Tata Steel for potential short-term gains.
India VIX jumps 100% in one month. Could fear levels take Nifty further down?
The India VIX nearly doubled in a month, reflecting rising fear among investors amid geopolitical tensions and global uncertainty. Surging crude prices and persistent foreign selling have triggered sharp equity declines, with the Nifty 50 down 8%, keeping markets volatile and investors cautious.